|
DIABETES IN CONTROL
|
Kristina
Sandstedt, MS
|
|
 Kristina
Sandstedt,
MS,
Clinical
Exercise
Physiologist,
Diabetes
Educator
“The
Role
of
Exercise
in
the
Treatment
of
Arthritis”,
Why
this
information
is
important
for
Diabetes
Educators
|
|
|
|
Evan
D.
Rosen,
M.D.,
Ph.D
|
|
Dr.
Evan
Rosen
 Winning
the
Battle,
but
Losing
the
War
|
|
|
|
Shafer
Monthly Feature
|
|
 “ANTIOXIDANTS”
Antioxidants
have
received
a
lot
of
attention
in
recent
years,
in
relation
to
wellness
and
disease
prevention.
More
studies
are
needed
to
better
understand
how
antioxidants
may
affect
diabetes
management
and
treatment.
Click
Here
By Sherri Shafer,
R.D., CDE,
View
Sherri's Archives
|
|
|
|
NOMINATE YOUR
CHOICE
|
|
Best
Diabetes
Product
or
Service
of
the
New
Millennium
Medical
Professionals
CHOICE
AWARD
CLICK
HERE
|
|
|
Dr. Eric S. Freedland
|
|
 Dr.
Eric Freedland
continues his series
Why
Focusing On Intensive Glucose Control With Drugs Alone Is
Counterproductive with
Part
10
Manipulating
Macronutrient
Ratios
Eric S. Freedland, MD
|
|
|
|
PRINT
THE NEWSLETTER
|
|
Print this weeks Newsletter Here.
Adobe
format
22
pages
Download
Adobe format
click here.
|
| |
|
|
|
Dr.
Thomas Burke Ph.D
|
-
 Dr
Thomas Burke brings
us a wound care case study by Alan
Kochman, PT, MS and Diane
Pogmore, RN, CWOCN
|
|
|
|
SUBSCRIBE |
|
|
|
|
Item #2
Diabetes
Management Market Predicted to Explode
Diabetes
management will grow at an annual rate of 11 percent during the next
decade, according to a market research report.
Consequently,
by 2010, annual sales for this market will reach $15 billion, Medtech
(Market Research Firm) said.
Because
of the large and growing diabetes patient population, the larger
undiagnosed population and the fact that patients are responsible for
99 percent of diabetes management responsibilities, “opportunities
for device manufacturers to develop patient-friendly solutions in this
market abound,” said Sharon O'Reilly, Medtech's president and chief
executive officer.
Among
the most promising diabetes management products are oral therapies,
glucose monitoring and insulin infusion products, Medtech continued.
By 2005, revenues for the glucose monitoring market will surpass $2.5
billion, and revenues for the external insulin pump market will reach
$625 million, Medtech predicted.
While
inhaled insulin products have captured headlines recently, Medtech
identified some roadblocks to growth in the inhaled insulin market.
“Pulmonary delivery is not expected to completely replace insulin
shots or insulin drugs,” the company said, noting that some studies
have “raised concerns about the effectiveness of inhaled insulin
over time, and possible adverse effects on the lungs.”
Medtech
also pointed to islet cell transplantation and pancreas
transplantation as promising possible cures for diabetes. However, the
company conceded that a shortage of suitable organs and the risks of
lifetime immunosuppression have hindered the use of such procedures
FACT
Alternate
Site Confusion?
Are
you confused about when it’s appropriate to use "alternate
site testing" for measuring blood glucose for your patients?
Getting a blood sample from the arm or thigh is less painful.
But blood flow is faster in the fingers...so rapid blood
glucose changes show up in the fingers BEFORE other sites.
FDA is now allowing alternate site testing with several meters...Accu-Chek
Active, FreeStyle, Glucometer Elite and DEX, One
Touch Ultra, InDuo, Sof-Tact.
You should tell patients using these meters that alternate sites are
okay only for ROUTINE testing of fasting and preprandial glucose
levels. Then advise them
to stick with fingertips when testing within 2 hours AFTER
meals...exercise...or insulin dose.
Don’t forget to recommend fingertip testing when checking for
hypoglycemia.
Diabetes
Care 2001;24:1303-4.
[an error occurred while processing this directive]
|
DIABETES NEWS FLASH
|
Dr.
Jennifer Larson
Feature
|
|
Dr
Jennifer Larson, MD,
University
of Nebraska Medical Center, gave
a very informative overview of Pancreas,
Islet, and Kidney Transplantation: Metabolic and Endocrine
Consequences, at the Endo2002 conference. We have an overview
of her presentation, click
here
|
|
|
|
TOP
DIABETES STORIES
|
|
New
Drug Restores Eyesight*
Click
Here
Diabetes
Management Market Predicted to Explode*
Click
Here
Night-Light
May Prevent Diabetic Eye Damage*
Click
Here
New
Test Predicts Which Type 2’s Will Become Type 1’s Within 5 Years*
Click
Here
|
|
|
|
FREE
WEBSITE!!!
|
|
Get
a
FREE
website
for
your
Diabetes
Organization.
Click
Here
To
Learn
More
|
|
NEW PRODUCT
|
|
 400
needles
that
pierce
the
skin
and
let
big
molecules
enter
the
bloodstream.
Drug
delivery
with
this
techniques
offers
several
advantages
over
pills
and
injections.
It
can
ensure
the
steady
release
of
medication
into
the
patient's
bloodstream
over
long
periods,
improving
the
efficacy
of a
dose.
It
can
prevent
the
rapid
breakdown
that
many
drugs
taken
orally
undergo
when
they
pass
through
the
digestive
system.
Click
here
for
more
information:
|
|
|
|
Dr Richard K. Bernstein
|
|
This
Months Corner:
 Dr.
Bernstein's
Feature:
Will
eating a low-fat
diet help you
live longer?
|
|
|
|
INSIDE
DIABETES
|
|
David
Kliff
 The
Pump Market - A
Market in
Turmoil
ADA
Highlights
David
Kliff, Publisher
The Diabetic Investor
|
|
|
|
In
2 Nutrition
|
|
Generate
Individualized meal plans for your patients!
See how your
patients can receive over 250 personalized recipes that are ideal
for individuals with diabetes, high cholesterol, heart disease and
weight management problems.
|
|
|
NEWS
FLASH
!!!
|
|
Over
One
million
US
adults
can't
afford
their
drugs
Click
Here
|
|
|
|
FREE
CME!
|
|
Free
CME
The
Hyperactive
Platelet
in
Type
2
Diabetes-
sponsored
by
Baylor
College
of
Medicine,
Houston,
Texas,
offers
2
hours
of
AMA
PRA
category
1
credit
To
access
this
free
on-line
activity,
visit
Click
Here
|
|
|
|
